1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Global Pemphigus Vulgaris Market Research Report Forecast to 2027

Global Pemphigus Vulgaris Market Research Report Forecast to 2027

  • March 2019
  • 95 pages
  • ID: 5773270
  • Format: PDF
  • By Market Research Future

Summary

Table of Contents

Search Inside

Global Pemphigus Vulgaris Market Research Report Forecast to 2027

A pemphigus vulgaris is a type of autoimmune disease in which the antibodies produced against the bacteria attack the normal cells and causes skin problems. Pemphigus vulgaris equally affects man and woman but middle and old age people are more prone to develop this condition. The major factors responsible for influencing the market growth are the increasing prevalence of pemphigus vulgaris, rising bacterial and viral infection, increasing geriatric population, and growing financial support by several private and public organizations for the research of chronic skin diseases. According to the International Pemphigus & Pemphigoid Foundation, it was predicted that approximately 40,000 to 50,000 people across the world and 2,500 people in the US had pemphigus disorder in 2017. On the other hand, factors such as high cost related to treatment, unfavorable reimbursement situation, and lack of awareness are expected to restrain the market growth.
The global pemphigus vulgaris market has been segmented based on treatment, route of administration, end user, and region.

Based on treatment, the market has been segmented into corticosteroids, immunosuppressants, biological therapies, and intravenous immunoglobulin (IVIG) therapy.
Based on route of administration, the market has been segmented into intravenous, subcutaneous, and oral.
Based on end user, the market has been segmented into hospitals and clinics, specialty dermatology clinics, and research and academic laboratories.
The global pemphigus vulgaris market is expected to register a CAGR of 8.0% during the forecast period of 2018 to 2027.

Key Players

Almirall, S.A, Argenx SE, Biogen Inc., F. Hoffmann-La Roche, Syntimmune, Pfizer Inc., Novartis AG, Sanofi, Janssen Global Services, LLC, Principia Biopharma, and others.

Study Objectives

• To provide a detailed analysis of the market structure along with the forecast of various segments and sub-segments of the global pemphigus vulgaris market
• To provide insights into factors affecting the market growth
• To analyze the pemphigus vulgaris market based on various tools such as supply chain analysis and Porter’s five force analysis
• To provide historical and forecast revenue of market segments and sub-segments with respect to regions and their respective key countries
• To provide country-level analysis of the market with respect to the current market size and future perspective
• To provide country-level analysis of the market for segments by product, type, end user, and region
• To provide strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market
• To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments in the global pemphigus vulgaris market

Target Audience

• Pharmaceutical and biotechnology companies
• Hospitals & clinics
• Academic research institutes
• Government institutes

Key Findings

• The global pemphigus vulgaris market is expected to register a CAGR of 8.0% during the forecast period of 2018–2027
• Based on treatment, the corticosteroids segment accounted for the largest market share of 28.6% in 2017, with a market value of USD 82.60 million
• Based on route of administration, the oral segment accounted for the largest market share of 26.6% in 2017, with a market value of USD 77.08 million
• Based on end user, the hospitals and clinics segment accounted for the largest market share in 2017, with a market value of USD 129.70 million
• The Americas holds the largest share of the global pemphigus vulgaris market which is expected to reach USD 297.41 million by 2027
• Asia-Pacific is the fastest growing market, which is expected to register a CAGR of 8.2% over 2018 to 2027

Regional Analysis

• Americas
o North America
US
Canada
o South America
• Europe
o Germany
o France
o UK
o Italy
o Spain
o Rest of Europe
• Asia-Pacific
o Japan
o China
o India
o Australia
o South Korea
o Rest of Asia-Pacific
• Middle East & Africa
o Middle East
o Africa

Companies Mentioned

Almirall, S.A
Argenx SE
Biogen Inc.
F. Hoffmann-La Roche
Syntimmune
Pfizer Inc.
Novartis AG
Sanofi
Janssen Global Services, LLC
Principia Biopharma
Others

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibody Markets in China

Monoclonal Antibody Markets in China

  • $ 4000
  • October 2019

China’s demand for Monoclonal Antibody has grown at a fast pace in the past decade.In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth ...

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019

  • $ 3500
  • August 2019

Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019SummaryAccording to the recently published report ’Interleukin 1 Receptor Associated Kinase 4 - Pipeline Review, H2 2019’; Interleukin ...

Primary Sclerosing Cholangitis - Pipeline Review, H2 2019

Primary Sclerosing Cholangitis - Pipeline Review, H2 2019

  • $ 2000
  • September 2019

Primary Sclerosing Cholangitis - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Primary Sclerosing Cholangitis - Pipeline Review, H2 2019, provides an overview ...

Colitis - Pipeline Review, H2 2019 $ 2000 September 2019


ref:plp2019

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on